MA S1635

Amends Section 24B ½ of Chapter 112 to expand collaborative drug therapy management authority for retail pharmacists working under physician supervision

Authorizes retail pharmacists with collaborative practice agreements to issue initial prescriptions for Schedule II-VI controlled substances specifically for treating substance use disorders

Limits retail pharmacy collaborative practice to patients 18 years or older who are referred by the supervising physician and consent to the collaboration

Requires prescriptions issued by collaborating pharmacists to match the diagnosis specified in the physician's referral, with a copy sent to the supervising physician within 24 hours

Expands the list of conditions retail pharmacists can co-manage to include substance use disorders alongside existing conditions like diabetes, hypertension, asthma, and HIV/AIDS